This event will discuss how emerging biology and cutting-edge technologies are pioneering the medicines of tomorrow. Bringing together scientists, researchers and entrepreneurs with bold ideas to serve our shared ambitions in creating the next generation of therapeutics to cure more patients around the world. The 2024 R&I meeting – based in Manchester – will comprise the following four main sessions.

Track 1 – Animal-free drug discovery. Emma Shepherd (Aston University) & Mike Morton (Apconix)

Track 2 – Oncology – Thinking the unthinkable and drugging the undruggable. Liz Anderson (CRL) & Susan Critchlow (AstraZeneca)

Track 3 – New horizons in tackling antimicrobial resistance. Bev Isherwood (MDC) & Lisa Dawson (Charles River Laboratories)

Track 4 – Mass spectrometry and ‘omics. Zack Gurard-Levin (Charles River Laboratories) & Marcus Bantscheff (GSK)

Event Link here.